Italia markets closed
FTSE MIB
35.398,82 -11,31 (-0,03%) Dow Jones
40.003,59 +134,21 (+0,34%) Nasdaq
16.685,97 -12,35 (-0,07%) Nikkei 225
38.787,38 -132,88 (-0,34%) Petrolio
80,00 +0,77 (+0,97%) Bitcoin EUR
61.426,96 +1.240,39 (+2,06%)
GSK plc (GSK.L)
LSE - LSE Prezzo differito. Valuta in GBp (0.01 GBP).
Aggiungi a watchlist
Alla chiusura: 04:51PM BST
| Chiusura precedente | 1.783,50 |
| Aperto | 1.773,50 |
| Denaro | 1.700,00 x 0 |
| Lettera | 1.800,00 x 0 |
| Min-Max giorno | 1.764,50 - 1.779,50 |
| Intervallo di 52 settimane | 1.302,60 - 1.823,50 |
| Volume | |
| Media Volume | 7.762.452 |
| Capitalizzazione | 73,573B |
| Beta (5 anni mensile) | 0,27 |
| Rapporto PE (ttm) | 16,28 |
| EPS (ttm) | 1,09 |
| Prossima data utili | 31 lug 2024 |
| Rendimento e dividendo (futuro) | 0,60 (3,36%) |
| Data ex dividendo | 16 mag 2024 |
| Stima target 1A | N/D |
GlobeNewswireGlobal CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic
© 2024 Yahoo. Tutti i diritti riservati.